Announcements and Notices - [Inside Information]

PegBio Co., Ltd. conducts biotechnology businesses. The Company develops innovative treatments for chronic diseases and metabolic diseases. PegBio provides its services throughout Japan.

Inside Information Announcement
Filing With The Csrc Regarding The Application For The
Proposed Implementation Of H Share Full Circulation

Announcements and Notices - [Other - Miscellaneous]

Voluntary Announcement Notice About Voluntary Extension Of Lock-Up Period Given By A Cornerstone Investor

Announcements and Notices - [Other - Business Update]

Voluntary Announcement - 
China Nmpa Granted Approval Of Nda For Pb-119

Announcements and Notices - [Change in a Director's or Supervisor's Biographical Details]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

PegBio (2565 HK)

Inside Information Announcement Filing With The Csrc Regarding The Application For The Proposed Implementation Of H Share Full Circulation

Voluntary Announcement Notice About Voluntary Extension Of Lock-Up Period Given By A Cornerstone Investor

Voluntary Announcement - China Nmpa Granted Approval Of Nda For Pb-119

Voluntary Dissolution Of A Subsidiary And Update On Director'S Information

Voluntary Announcement - Proposed Grant Of An Exclusive License For Visepegenatide (Pb-119) In The Middle East And Africa

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)